Beat Imhof
18Patents
3h-index
13Co-inventors
57Inventor score
Filing activity: Aug 12, 1994 → Jan 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7642341B2 | Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer | Chemistry; Metallurgy | 5 | Expired |
| US7790863B2 | Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer | Physics | 5 | Active |
| US8093010B2 | Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US8007797B2 | Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use | Chemistry; Metallurgy | 3 | Active |
| US11492333B2 | Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer | Human Necessities | 2 | Active |
| US9096662B2 | Methods and compositions for modulation of Olfml3 mediated angiogenisis | Chemistry; Metallurgy | 1 | Active |
| US5538725A | Method of inhibiting metastasis by anti-.alpha.6-integrin-antibodies | Human Necessities | 1 | Expired |
| US10385129B2 | JAM-C antibodies and methods for treatment of cancer | Physics | 1 | Active |
| US7670826B2 | Confluence regulated adhesion molecules useful in modulating vascular permeability | Emerging Cross-Sectional Technologies | 1 | Active |
| US9803014B2 | JAM-C antibodies and methods for treatment of cancer | Physics | 1 | Active |
| US7393651B2 | Confluence regulated adhesion molecules useful in modulating vascular permeability | Emerging Cross-Sectional Technologies | 1 | Expired |
| US12252472B1 | Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer | Human Necessities | 0 | Active |
| US10808026B2 | Monoclonal Olfml-3 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8663637B2 | Methods and compositions for modulation of Olfml3 mediated angiogenesis | Chemistry; Metallurgy | 0 | Active |
| US8143056B2 | Vascular adhesion molecules and modulation of their function | Emerging Cross-Sectional Technologies | 0 | Active |
| US7033794B2 | Basolateral sorting signal and inhibitors thereof | Human Necessities | 0 | Expired |
| US10759857B2 | JAM-C antibodies and methods for treatment of cancer | Physics | 0 | Active |
| US12240820B2 | Barbituric acid derivatives, their preparation and use thereof as leukocyte transmigration inhibitors and for treating inflammatory diseases, autoimmune diseases and cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.